Bristol-Myers Squibb Co.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bristol-Myers Squibb Co.
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
/ 
Frequently asked questions
To buy Bristol-Myers Squibb Co. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bristol-Myers Squibb Co. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bristol-Myers Squibb Co. is BMY:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bristol-Myers Squibb Co. has its primary listing on New York Stock Exchange. You can trade Bristol-Myers Squibb Co. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bristol-Myers Squibb Co. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bristol-Myers Squibb Co. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bristol-Myers Squibb Co..